Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cough/Cold Combination Final Monograph Includes Four-Ingredient Combos

This article was originally published in The Tan Sheet

Executive Summary

FDA has designated combinations of analgesic-antipyretic, expectorant and nasal decongestant ingredients, as well as analgesic-antipyretic, antitussive, expectorant and nasal decongestant combinations, as Category I in the final monograph on cough/cold combinations

You may also be interested in...



Antitussive Combo With Wick Delivery Needs Two Clinical Studies – FDA

Two clinical studies are needed to support cough/cold monograph status for a menthol/camphor/eucalyptus oil combination product with a wick delivery system, FDA stated at a recent "feedback" meeting on Lil' Drug Store's antitussive Vaporizer in a Bottle

Antitussive Combo With Wick Delivery Needs Two Clinical Studies – FDA

Two clinical studies are needed to support cough/cold monograph status for a menthol/camphor/eucalyptus oil combination product with a wick delivery system, FDA stated at a recent "feedback" meeting on Lil' Drug Store's antitussive Vaporizer in a Bottle

Antitussive Combo With Wick Delivery Needs Two Clinical Studies – FDA

Two clinical studies are needed to support cough/cold monograph status for a menthol/camphor/eucalyptus oil combination product with a wick delivery system, FDA stated at a recent "feedback" meeting on Lil' Drug Store's antitussive Vaporizer in a Bottle

Related Content

Topics

UsernamePublicRestriction

Register

PS094929

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel